Schulhoff Co News Today

Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock […]

Lockheed Martin Investment Management Co. trimmed its position in Kimco Realty Corp (NYSE:KIM – Free Report) by 21.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,343 shares of the real estate investment trust’s stock after selling 11,300 shares during the quarter. Lockheed […]

Pier 88 Investment Partners LLC decreased its position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 42.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,740 shares of the company’s stock after selling 1,280 shares […]

L3Harris Technologies (NYSE:LHX – Get Free Report) had its target price upped by equities research analysts at Barclays from $238.00 to $245.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price objective suggests a potential upside of 15.70% from the stock’s previous close. […]

Newmont (NYSE:NEM – Get Free Report) was downgraded by National Bank Financial from an “outperform overweight” rating to a “sector perform overweight” rating in a note issued to investors on Tuesday, Zacks.com reports. A number of other equities analysts also recently commented on the company. Scotiabank decreased their target price on Newmont from $50.00 to […]

Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) shares traded down 0.3% during mid-day trading on Wednesday . The stock traded as low as $386.42 and last traded at $387.29. 39,505 shares changed hands during trading, a decline of 84% from the average session volume of 247,935 shares. The stock had previously closed at $388.35. […]

Abrdn plc acquired a new position in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,303 shares of the company’s stock, valued at approximately $1,275,000. Several other large investors have also recently modified their […]

Jefferies Financial Group upgraded shares of Medpace (NASDAQ:MEDP – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday, MarketBeat.com reports. They currently have $450.00 price objective on the stock, up from their prior price objective of $340.00. MEDP has been the subject of several other reports. […]

Medpace (NASDAQ:MEDP – Get Free Report) had its price target lifted by research analysts at Guggenheim from $453.00 to $464.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 17.34% from the company’s […]

Medpace (NASDAQ:MEDP – Get Free Report) had its price target lifted by research analysts at Guggenheim from $453.00 to $464.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim’s price objective indicates a potential upside of 17.34% from the company’s […]